Maxigen Biotech Inc. (1783.TW) TAI

44.30

+0.15(+0.34%)

Updated at September 09 11:25AM

Currency In TWD

Valuation

Market Cap4.36B
Enterprise Value3.72B
P/E Ratio18.95
PEG Ratio0.19
Price/Sales Ratio5.17
Price/Book Ratio2.79
Enterprise/Revenue4.21
Enterprise/EBITDA12.28

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.27
Operating Margin0.3

Management Effectiveness

Return On Assets0.12
Return On Equity0.15

Income Statement

Revenue680.65M
Revenue/Share8.57
Gross Profit483.33M
EBITDA221.4M
Net Income190.17M
Diluted EPS2.12

Balance Sheet

Total Cash739.27M
Total Cash/Share8.28
Total Debt0
Total Debt/Equity0
Current Ratio3.43
Book Value Per Share15.82

Price History

52-Week Change-2.21
52-Week High55
52-Week Low35.55
Moving Average 50 Days43.73
Moving Average 200 Days45.64

Statistics

Average Volume64,862
Shares Outstanding89.68M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.83
Trailing Annual Dividend Yield1.88
Payout Ratio0.43
Last Split Factor21:20
Last Split DateSeptember 07, 2023